602
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Reproductive and fetal outcomes in women with epilepsy: a systematic review and meta-analysis

, , , , &
Article: 2351196 | Received 05 Feb 2024, Accepted 29 Apr 2024, Published online: 12 May 2024

References

  • Epilepsy: a public health imperative. Geneva: World Health Organization; 2019.
  • Richmond JR, Krishnamoorthy P, Andermann E, et al. Epilepsy and pregnancy: an obstetric perspective. Am J Obstet Gynecol. 2004;190(2):1–13. doi:10.1016/j.ajog.2003.09.020.
  • Kaur TP, Sahu L, Rathore AM, et al. Obstetric outcomes in pregnant women with seizure disorder: a hospital-based, longitudinal study. Turk J Obstet Gynecol. 2020;17(3):161–169. doi:10.4274/tjod.galenos.2020.87300.
  • Borthen I, Eide MG, Veiby G, et al. Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG. 2009;116(13):1736–1742. doi:10.1111/j.1471-0528.2009.02354.x.
  • Tomson T, Battino D, Bromley R, et al. Executive summary: management of epilepsy in pregnancy: a report from the international league against epilepsy task force on women and pregnancy. Epilepsia. 2019;60(12):2343–2345. doi:10.1111/epi.16395.
  • Mazzone PP, Hogg KM, Weir CJ, et al. Comparison of perinatal outcomes for women with and without epilepsy: a systematic review and meta-analysis. JAMA Neurol. 2023;80(5):484–494. doi:10.1001/jamaneurol.2023.0148.
  • Işıkalan MM, Gündoğan KM, Acar A. Peripartum hemorrhage and other obstetric and neonatal outcomes in pregnant women with epilepsy: a single-center study. Epilepsy Res. 2021;171:106566. doi:10.1016/j.eplepsyres.2021.106566.
  • Viale L, Allotey J, Cheong-See F, et al. Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Lancet. 2015;386(10006):1845–1852. doi:10.1016/s0140-6736(15)00045-8.
  • Wells GA, Wells, G, Shea B, et al. editors. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014.
  • Meador KJ, Pennell PB, May RC, et al. Fetal loss and malformations in the MONEAD study of pregnant women with epilepsy. Neurology. 2020;94(14):E1502–E1511. doi:10.1212/WNL.0000000000008687.
  • Van Marter LJ, Pennell PB, Brown C, et al. Neonatal ­outcomes in the MONEAD study of pregnant women with epilepsy. J Pediatr. 2021;X:7. doi:10.1016/j.ympdx.2021.100073.
  • Danielsson KC, Gilhus NE, Borthen I, et al. Maternal complications in pregnancy and childbirth for women with epilepsy: time trends in a nationwide cohort. PLoS One. 2019;14(11):e0225334. doi:10.1371/journal.pone.0225334.
  • Decker BM, Thibault D, Davis KA, et al. A nationwide analysis of maternal morbidity and acute postpartum readmissions in women with epilepsy. Epilepsy Behav. 2021;117:107874. doi:10.1016/j.yebeh.2021.107874.
  • Chen YH, Chiou HY, Lin HC, et al. Affect of seizures during gestation on pregnancy outcomes in women with epilepsy. Arch Neurol. 2009;66(8):979–984. doi:10.1001/archneurol.2009.142.
  • Razaz N, Tomson T, Wikström A-K, et al. Association between pregnancy and perinatal outcomes among women with epilepsy. JAMA Neurol. 2017;74(8):983–991. doi:10.1001/jamaneurol.2017.1310.
  • Huang CY, Dai YM, Feng LM, et al. Clinical characteristics and outcomes in pregnant women with epilepsy. Epilepsy Behav. 2020;112:107433. doi:10.1016/j.yebeh.2020.107433.
  • Borthen I, Eide MG, Daltveit AK, et al. Delivery outcome of women with epilepsy: a population-based cohort study. BJOG. 2010;117(12):1537–1543. doi:10.1111/j.1471-0528.2010.02694.x.
  • Borthen I, Eide MG, Daltveit AK, et al. Obstetric outcome in women with epilepsy: a hospital-based, retrospective study. BJOG. 2011;118(8):956–965. doi:10.1111/j.1471-0528.2011.03004.x.
  • Farmen AH, Grundt JH, Nakling JO, et al. Increased rate of acute caesarean sections in women with epilepsy: results from the Oppland perinatal database in Norway. Eur J Neurol. 2019;26(4):617–623. doi:10.1111/ene.13865.
  • Thomas SV, Sindhu K, Ajaykumar B, et al. Maternal and obstetric outcome of women with epilepsy. Seizure. 2009;18(3):163–166. doi:10.1016/j.seizure.2008.08.010.
  • Sarusi MM, Wainstock T, Sheiner E, et al. Maternal epilepsy- perinatal outcome and long-term neurological morbidity of the offspring: a population-based cohort study. Arch Gynecol Obstet. 2022;305(1):55–62. doi:10.1007/s00404-021-06114-7.
  • Gyamfi-Bannerman C, Huang Y, Bateman BT, et al. Maternal morbidity and mortality associated with epilepsy. J Mater Fetal Neonatal Med. 2021;35(25):7917–7923. doi:10.1080/14767058.2021.1938528.
  • MacDonald SC, Bateman BT, McElrath TF, et al. Mortality and morbidity during delivery hospitalization among pregnant women with epilepsy in the United States. JAMA Neurol. 2015;72(9):981–988. doi:10.1001/jamaneurol.2015.1017.
  • Melikova S, Bagirova H, Magalov S. The impact of maternal epilepsy on delivery and neonatal outcomes. Childs Nerv Syst. 2020;36(4):775–782. doi:10.1007/s00381-019-04435-2.
  • Hiilesmaa VK, Bardy A, Teramo K. Obstetric outcome in women with epilepsy. Am J Obstet Gynecol. 1985;152(5):499–504. doi:10.1016/0002-9378(85)90615-5.
  • Sabers A, aRogvi-Hansen B, Dam M, et al. Pregnancy and epilepsy: a retrospective study of 151 pregnancies. Acta Neurol Scand. 1998;97(3):164–170. doi:10.1111/j.1600-0404.1998.tb00631.x.
  • Soontornpun A, Choovanichvong T, Tongsong T. Pregnancy outcomes among women with epilepsy: a retrospective cohort study. Epilepsy Behav. 2018;82:52–56. doi:10.1016/j.yebeh.2018.03.001.
  • Salman L, Shmueli A, Ashwal E, et al. The impact of maternal epilepsy on perinatal outcome in singleton gestations. J Mater Fetal Neonatal Med. 2018;31(24):3283–3286. doi:10.1080/14767058.2017.1368483.
  • Vanya M, Árva-Nagy N, Szili K, et al. Effects of maternal epilepsy and antiepileptic therapy in women during pregnancy. Ideggyogyaszati Szemle. 2015;68(3-4):105–112.
  • Mueller BA, Cheng-Hakimian A, Crane DA, et al. Morbidity and rehospitalization postpartum among women with epilepsy and their infants: a population-based study. Epilepsy Behav. 2022;136:108943. doi:10.1016/j.yebeh.2022.108943.
  • McElrath TF, Druzin ML, Van Marter LJ, et al. The obstetrical care and delivery experience of women with ­epilepsy in the MODEAD study. Am J Perinatol. 2022;41(7):935–943. doi:10.1055/a-1788-4791.
  • Katz O, Levy A, Wiznitzer A, et al. Pregnancy and perinatal outcome in epileptic women: a population-based study. J Mater Fetal Neonatal Med. 2006;19(1):21–25. doi:10.1080/14767050500434096.
  • McPherson JA, Harper LM, Odibo AO, et al. Maternal seizure disorder and risk of adverse pregnancy outcomes. Am J Obstet Gynecol. 2013;208(5):378.e371–378.e375. doi:10.1016/j.ajog.2013.01.048.
  • Veiby G, Daltveit AK, Engelsen BA, et al. Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia. 2009;50(9):2130–2139. doi:10.1111/j.1528-1167.2009.02147.x.
  • Steegers-Theunissen RPM, Renier WO, Borm GF, et al. Factors influencing the risk of abnormal pregnancy outcome in epileptic women: a multi-Centre prospective study. Epilepsy Res. 1994;18(3):261–269. doi:10.1016/0920-1211(94)90046-9.
  • Hvas CL, Henriksen TB, Ostergaard JR, et al. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. BJOG. 2000;107(7):896–902. doi:10.1111/j.1471-0528.2000.tb11089.x.
  • Laskowska M, Leszczyńska-Gorzelak B, Oleszczuk J. Pregnancy in women with epilepsy. Gynecol Obstet Invest. 2001;51(2):99–102. doi:10.1159/000052902.
  • Tanganelli P, Regesta G. Epilepsy, pregnancy, and major birth anomalies: an italian prospective, controlled study. Neurology. 1992;42(4 Suppl 5):89–93.
  • Saleh AM, Abotalib ZM, Al-Ibrahim AA, et al. Comparison of maternal and fetal outcomes, in epileptic and non-epileptic women. Saudi Med J. 2008;29(2):261–266.
  • Goel P, Devi L, Saha PK, et al. Maternal and perinatal outcome in pregnancy with epilepsy. Internet J Gynecol Obstetr. 2005;5. doi:10.5580/102b.
  • Artama M, Gissler M, Malm H, et al. Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland. Drug Saf. 2013;36(5):359–369. doi:10.1007/s40264-013-0052-8.
  • Danielsson KC, Borthen I, Morken NH, et al. Hypertensive pregnancy complications in women with epilepsy and antiepileptic drugs: a population-based cohort study of first pregnancies in Norway. BMJ Open. 2018;8(4):e020998. doi:10.1136/bmjopen-2017-020998.
  • Bider-Canfield Z, Martinez MP, Wang X, et al. Maternal obesity, gestational diabetes, breastfeeding and childhood overweight at age 2 years. Pediatr Obes. 2017;12(2):171–178. doi:10.1111/ijpo.12125.
  • Schiff MA, Holt VL, Daling JR. Maternal and infant outcomes after injury during pregnancy in Washington state from 1989 to 1997. J Trauma. 2002;53(5):939–945. doi:10.1097/00005373-200211000-00021.
  • Alexander BT. Placental insufficiency leads to development of hypertension in growth-restricted offspring. Hypertension. 2003;41(3):457–462. doi:10.1161/01.Hyp.0000053448.95913.3d.
  • Bromley R, Adab N, Bluett-Duncan M, et al. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev. 2023;8(8):Cd010224. doi:10.1002/14651858.CD010224.pub3.
  • Tomson T, Battino D, Perucca E. Teratogenicity of antiepileptic drugs. Curr Opin Neurol. 2019;32(2):246–252. doi:10.1097/wco.0000000000000659.
  • Bromley R, Weston J, Adab N, et al. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev. 2014;2014(10):Cd010236. doi:10.1002/14651858.CD010236.pub2.
  • Tomson T, Battino D, Bonizzoni E, et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17(6):530–538. doi:10.1016/s1474-4422(18)30107-8.
  • Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013;12(3):244–252. doi:10.1016/s1474-4422(12)70323-x.
  • Pennell PB, Karanam A, Meador KJ, et al. Antiseizure medication concentrations during pregnancy: results from the maternal outcomes and neurodevelopmental effects of antiepileptic drugs (MONEAD) study. JAMA Neurol. 2022;79(4):370–379. doi:10.1001/jamaneurol.2021.5487.
  • Knight R, Wittkowski A, Bromley RL. Neurodevelopmental outcomes in children exposed to newer antiseizure medications: a systematic review. Epilepsia. 2021;62(8):1765–1779. doi:10.1111/epi.16953.
  • Veroniki AA, Cogo E, Rios P, et al. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med. 2017;15(1):95. doi:10.1186/s12916-017-0845-1.
  • Dreier JW, Bjørk MH, Alvestad S, et al. Prenatal exposure to antiseizure medication and incidence of childhood- and Adolescence-Onset psychiatric disorders. JAMA Neurol. 2023;80(6):568–577. doi:10.1001/jamaneurol.2023.0674.
  • Vazquez B, Tomson T, Dobrinsky C, et al. Perampanel and pregnancy. Epilepsia. 2021;62(3):698–708. doi:10.1111/epi.16821.
  • Bjørk MH, Zoega H, Leinonen MK, et al. Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability. JAMA Neurol. 2022;79(7):672–681. doi:10.1001/jamaneurol.2022.1269.
  • Honybun E, Cockle E, Malpas CB, et al. Neurodevelopmental and functional outcomes following in utero exposure to antiseizure medication: a systematic review. Neurology. 2024;102(8):e209175. doi:10.1212/wnl.0000000000209175.
  • Belcastro V, Striano P. Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy. Epilepsy Res. 2012;102(1-2):1–7. doi:10.1016/j.eplepsyres.2012.07.003.
  • Linnebank M, Moskau S, Semmler A, et al. Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann Neurol. 2011;69(2):352–359. doi:10.1002/ana.22229.
  • Tomson T, Battino D, Bromley R, et al. Global survey of guidelines for the management of epilepsy in pregnancy: a report from the international league against epilepsy task force on women and pregnancy. Epilepsia Open. 2020;5(3):366–370. doi:10.1002/epi4.12420.
  • Meador KJ, Pennell PB, May RC, et al. Effects of periconceptional folate on cognition in children of women with epilepsy: NEAD study. Neurology. 2020;94(7):e729–e740. doi:10.1212/wnl.0000000000008757.
  • Bjørk M, Riedel B, Spigset O, et al. Association of folic acid supplementation during pregnancy with the risk of autistic traits in children exposed to antiepileptic drugs in utero. JAMA Neurol. 2018;75(2):160–168. doi:10.1001/jamaneurol.2017.3897.
  • Husebye ESN, Gilhus NE, Riedel B, et al. Verbal abilities in children of mothers with epilepsy: association to maternal folate status. Neurology. 2018;91(9):e811–e821. doi:10.1212/wnl.0000000000006073.
  • Gorski JR, Lebofsky M, Rozman K. Corticosterone decreases toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in hypophysectomized rats. J Toxicol Environ Health. 1988;25(3):349–360. doi:10.1080/15287398809531214.
  • Husebye ESN, Wendel AWK, Gilhus NE, et al. Plasma unmetabolized folic acid in pregnancy and risk of autistic traits and language impairment in antiseizure medication-exposed children of women with epilepsy. Am J Clin Nutr. 2022;115(5):1432–1440. doi:10.1093/ajcn/nqab436.
  • Alvestad S, Husebye ESN, Christensen J, et al. Folic acid and risk of preterm birth, preeclampsia, and fetal growth restriction among women with epilepsy: a ­prospective cohort study. Neurology. 2022;99(6):e605–e615. doi:10.1212/wnl.0000000000200669.
  • Morrow JI, Hunt SJ, Russell AJ, et al. Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK epilepsy and pregnancy register. J Neurol Neurosurg Psychiatry. 2009;80(5):506–511. doi:10.1136/jnnp.2008.156109.
  • Mawer G, Briggs M, Baker GA, et al. Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure. 2010;19(2):112–119. doi:10.1016/j.seizure.2009.11.008.
  • Ban L, Fleming KM, Doyle P, et al. Congenital anomalies in children of mothers taking antiepileptic drugs with and without periconceptional high dose folic acid use: a Population-Based cohort study. PLoS One. 2015;10(7):e0131130. doi:10.1371/journal.pone.0131130.
  • Thomas SV, Jose M, Divakaran S, et al. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: results from a pregnancy registry in South India. Epilepsia. 2017;58(2):274–281. doi:10.1111/epi.13632.
  • Vajda FJE, O’Brien TJ, Graham JE, et al. Folic acid dose, valproate, and fetal malformations. Epilepsy Behav. 2021;114(Pt A):107569. doi:10.1016/j.yebeh.2020.107569.
  • Stephen LJ, Harden C, Tomson T, et al. Management of epilepsy in women. Lancet Neurol. 2019;18(5):481–491. doi:10.1016/s1474-4422(18)30495-2.
  • Vegrim HM, Dreier JW, Alvestad S, et al. Cancer risk in children of mothers with epilepsy and high-dose folic acid use during pregnancy. JAMA Neurol. 2022;79(11):1130–1138. doi:10.1001/jamaneurol.2022.2977.